FinTech

Page 6

Eli Lilly Q1 2026 results reflecting tirzepatide sales surge, Mounjaro and Zepbound growth, and expanding GLP-1 drug market demand

Eli Lilly Posts 56% Revenue Surge as Incretin Empire Expands

Read more

Novartis Q1 2026 earnings show Novartis Kisqali growth, Novartis Pluvicto sales, Novartis Entresto decline and Novartis pharma growth across Novartis drug portfolio, Novartis financial results, Novartis revenue and growth, Novartis oncology drugs, Novartis patent expiry impact, Novartis growth brands, Novartis drug sales growth and Novartis pharma strategy

Novartis Q1 2026 Earnings Show Growth Beyond Patent Cliff

Read more

OpenAI pharmaceutical partnership Novo Nordisk AI drug discovery healthcare AI digital transformation Novo Nordisk OpenAI alliance AI strategy

Novo Nordisk and OpenAI Join Forces to Reshape Drug Discovery

Read more